Literature DB >> 9199875

Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia.

L Paemen1, P M Jansen, P Proost, J Van Damme, G Opdenakker, E Hack, F B Taylor.   

Abstract

Intravenous injection of sublethal or lethal doses of Escherichia coli in baboons resulted in increased serum levels of the matrix metalloprotease gelatinase B and the chemokine monocyte chemotactic protein 2 (MCP-2). In both animal models, gelatinase B appeared faster than MCP-2. After sublethal challenge, serum levels of gelatinase B and MCP-2 were found to be correlated, reaching peak levels between 2 and 4 h after bacterial challenge. After lethal challenge, however, MCP-2 tended to increase until 10 h. The kinetics of appearance suggest induction of release of gelatinase B and de novo synthesis and secretion of MCP-2, both by endotoxin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199875     DOI: 10.1006/cyto.1996.0183

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

Review 1.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

2.  Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

Authors:  B Dubois; S Masure; U Hurtenbach; L Paemen; H Heremans; J van den Oord; R Sciot; T Meinhardt; G Hämmerling; G Opdenakker; B Arnold
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

3.  Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.

Authors:  M M Lalu; J Cena; R Chowdhury; A Lam; R Schulz
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

4.  Rac1 regulates platelet shedding of CD40L in abdominal sepsis.

Authors:  Rundk Hwaiz; Milladur Rahman; Enming Zhang; Henrik Thorlacius
Journal:  Lab Invest       Date:  2014-07-21       Impact factor: 5.662

5.  Matrix metalloproteinase-9 as new biomarkers of severity in multiple organ dysfunction syndrome caused by trauma and infection.

Authors:  Lin Teng; Min Yu; Jun-ming Li; Hua Tang; Jing Yu; Li-hua Mo; Jing Jin; Xian-zhe Liu
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

6.  Urinary MMP-9/NGAL complex in children with acute cystitis.

Authors:  Sami Hatipoglu; Esra Sevketoglu; Asuman Gedikbasi; Alev Yilmaz; Aysel Kiyak; Mehmet Mulazimoglu; Gonul Aydogan; Tevfik Ozpacaci
Journal:  Pediatr Nephrol       Date:  2011-05-10       Impact factor: 3.714

7.  Production of matrix metalloproteinases in response to mycobacterial infection.

Authors:  M Quiding-Järbrink; D A Smith; G J Bancroft
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice.

Authors:  A Pagenstecher; A K Stalder; C L Kincaid; B Volk; I L Campbell
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

9.  Matrix-metalloproteinase-2, -8 and -9 in serum and skin blister fluid in patients with severe sepsis.

Authors:  Fiia P Gäddnäs; Meeri M Sutinen; Marjo Koskela; Taina Tervahartiala; Timo Sorsa; Tuula A Salo; Jouko J Laurila; Vesa Koivukangas; Tero I Ala-Kokko; Aarne Oikarinen
Journal:  Crit Care       Date:  2010-03-31       Impact factor: 9.097

Review 10.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.